1252 related articles for article (PubMed ID: 19078869)
1. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo.
Rajkhowa M; Brett S; Cuthbertson DJ; Lipina C; Ruiz-Alcaraz AJ; Thomas GE; Logie L; Petrie JR; Sutherland C
Biochem J; 2009 Mar; 418(3):665-71. PubMed ID: 19053948
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
Diamanti-Kandarakis E; Papavassiliou AG
Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
[TBL] [Abstract][Full Text] [Related]
6. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
Højlund K; Glintborg D; Andersen NR; Birk JB; Treebak JT; Frøsig C; Beck-Nielsen H; Wojtaszewski JF
Diabetes; 2008 Feb; 57(2):357-66. PubMed ID: 17977950
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
8. Androgens in polycystic ovary syndrome: the role of exercise and diet.
Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
[TBL] [Abstract][Full Text] [Related]
9. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
Corbould A
Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
[TBL] [Abstract][Full Text] [Related]
10. Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity.
Ciaraldi TP
J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1291-3. PubMed ID: 11117672
[TBL] [Abstract][Full Text] [Related]
11. Genomic variants in polycystic ovary syndrome.
Luque-Ramírez M; San Millán JL; Escobar-Morreale HF
Clin Chim Acta; 2006 Apr; 366(1-2):14-26. PubMed ID: 16337616
[TBL] [Abstract][Full Text] [Related]
12. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-2 in the adipose tissue from patients with polycystic ovary syndrome].
Qiu HY; Chu YL; Li M; Sun YY; Li HF
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):116-9. PubMed ID: 15840293
[TBL] [Abstract][Full Text] [Related]
13. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.
Mukherjee S; Maitra A
Indian J Med Res; 2010 Jun; 131():743-60. PubMed ID: 20571162
[TBL] [Abstract][Full Text] [Related]
14. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.
Björnholm M; Zierath JR
Biochem Soc Trans; 2005 Apr; 33(Pt 2):354-7. PubMed ID: 15787605
[TBL] [Abstract][Full Text] [Related]
15. Exercise training-induced improvements in insulin action.
Hawley JA; Lessard SJ
Acta Physiol (Oxf); 2008 Jan; 192(1):127-35. PubMed ID: 18171435
[TBL] [Abstract][Full Text] [Related]
16. [Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus].
Jaffiol C; Rouard M; Macari F; Lautier C; Ait el Mkadem S; Méchaly I; Brun JF; Renard E; Cros G; Bringer J; Grigorescu F
Bull Acad Natl Med; 1999; 183(9):1761-75; discussion 1775-7. PubMed ID: 10987057
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in patients with polycystic ovary syndrome.
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome and type 2 diabetes mellitus.
De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
[TBL] [Abstract][Full Text] [Related]
19. [Expression of insulin receptor substrate 1 and phosphorylation of tyrosine in adipose tissue of polycystic ovary syndrome].
Wang ZC; Gu XF; Yang DZ; Kuang JQ
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):120-3. PubMed ID: 15840294
[TBL] [Abstract][Full Text] [Related]
20. Obesity, inflammation, and insulin resistance--a mini-review.
Zeyda M; Stulnig TM
Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
